- Home
- RSKD vs MPLT Comparison
RSKD vs MPLT Comparison
Compare RSKD & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RSKD | MPLT |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 755.1M | 772.7M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RSKD | MPLT |
|---|---|---|
| Price | $4.52 | $19.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $5.91 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 463.0K | 183.3K |
| Earning Date | 03-04-2026 | 02-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $338,838,000.00 | N/A |
| Revenue This Year | $6.65 | N/A |
| Revenue Next Year | $9.41 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.54 | N/A |
| 52 Week Low | $3.94 | $12.24 |
| 52 Week High | $6.00 | $21.55 |
Technical Indicators
Market Signals| Indicator | RSKD | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 37.00 | 56.16 |
| Support Level | $4.51 | $17.06 |
| Resistance Level | $4.64 | $19.68 |
| Average True Range (ATR) | 0.12 | 1.79 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 11.57 | 68.64 |
Price Performance
Historical ComparisonAbout RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.